Nuwellis (NUWE) Current Leases (2019 - 2026)

Nuwellis (NUWE) reported Current Leases of $265000.0 for Q1 2026, up 9.05% on a YoY basis from $243000.0 in Q1 2025, and up 1.53% quarter-over-quarter from $261000.0 in Q4 2025.

Nuwellis (NUWE) Current Leases (2019 - 2026) Analysis & Trends

Nuwellis has reported Current Leases for 8 years, with the latest figure at $265000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 9.05% year-over-year to $265000.0; the trailing twelve-month figure through Mar 2026 stood at $265000.0 (up 9.05% YoY), and the FY2025 full-year result was $261000.0, up 9.66% from the prior year.
  • Current Leases for Q1 2026 stood at $265000.0, up from $261000.0 in the prior quarter.
  • The five-year high for Current Leases was $265000.0 in Q1 2026, with the low at $8000.0 in Q3 2023.
  • Historically, Current Leases has averaged $180411.8 across 5 years, with a median of $221000.0 in 2024.
  • Annual changes were most pronounced in 2023 — Current Leases sank 95.81% — and 2024, when it jumped 2800.0%.
  • Nuwellis' Current Leases stood at $196000.0 in 2022, then climbed by 10.2% to $216000.0 in 2023, then rose by 10.19% to $238000.0 in 2024, then advanced by 9.66% to $261000.0 in 2025, then rose by 1.53% to $265000.0 in 2026.
  • The last three Current Leases figures came in at $265000.0 (Q1 2026), $261000.0 (Q4 2025), and $255000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 35.80 Mn
10 Nuwellis 279,710.00 -1.80 Mn 1.68 Mn 265,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 265,000.00
Dec 31, 2025 261,000.00
Sep 30, 2025 255,000.00
Jun 30, 2025 249,000.00
Mar 31, 2025 243,000.00
Dec 31, 2024 238,000.00
Sep 30, 2024 232,000.00
Jun 30, 2024 226,000.00
Mar 31, 2024 221,000.00
Dec 31, 2023 216,000.00
Sep 30, 2023 8,000.00
Jun 30, 2023 14,000.00
Mar 31, 2023 201,000.00
Dec 31, 2022 196,000.00
Sep 30, 2022 191,000.00
Jun 30, 2022 27,000.00
Mar 31, 2022 24,000.00
Dec 31, 2021 167,000.00
Sep 30, 2021 27,000.00
Jun 30, 2021 160,000.00